Literature DB >> 24919167

Why are the outcomes in patients with schizophrenia so poor?

Robert B Zipursky1.   

Abstract

Despite many advances in the treatment of schizophrenia over the past 50 years, the outcomes for many patients with schizophrenia remain poor. While the majority of patients with a first episode of schizophrenia may be able to achieve and maintain a remission of symptoms, only 1 in 7 patients are likely to meet criteria for recovery. These findings could be easily reconciled if schizophrenia could be established to be a progressive brain disease. Results from longitudinal studies of brain structure, cognitive functioning, and clinical outcomes, however, do not support this view. The poor outcomes so commonly observed are likely best explained by poor access to treatment, poor engagement in ongoing care, poor treatment response, and poor adherence together with the cumulative negative impact of substance abuse, comorbid psychiatric disorders, cognitive deficits, and multiple social determinants of health. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24919167     DOI: 10.4088/JCP.13065su1.05

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  12 in total

1.  Recovery, not progressive deterioration, should be the expectation in schizophrenia.

Authors:  Robert B Zipursky; Ofer Agid
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

2.  The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings From the Multinational EU-GEI Study.

Authors:  Baptiste Pignon; Mohamed Lajnef; James B Kirkbride; Hugo Peyre; Aziz Ferchiou; Jean-Romain Richard; Grégoire Baudin; Sarah Tosato; Hannah Jongsma; Lieuwe de Haan; Ilaria Tarricone; Miguel Bernardo; Eva Velthorst; Mauro Braca; Celso Arango; Manuel Arrojo; Julio Bobes; Cristina Marta Del-Ben; Marta Di Forti; Charlotte Gayer-Anderson; Peter B Jones; Caterina La Cascia; Antonio Lasalvia; Paulo Rossi Menezes; Diego Quattrone; Julio Sanjuán; Jean-Paul Selten; Andrea Tortelli; Pierre-Michel Llorca; Jim van Os; Bart P F Rutten; Robin M Murray; Craig Morgan; Marion Leboyer; Andrei Szöke; Franck Schürhoff
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 9.306

Review 3.  Strategies to improve medication adherence in patients with schizophrenia: the role of support services.

Authors:  Peggy El-Mallakh; Jan Findlay
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-16       Impact factor: 2.570

4.  Neuronal activity patterns in the mediodorsal thalamus and related cognitive circuits are modulated by metabotropic glutamate receptors.

Authors:  C S Copeland; S A Neale; T E Salt
Journal:  Neuropharmacology       Date:  2015-01-07       Impact factor: 5.250

Review 5.  Clinical predictors of therapeutic response to antipsychotics in schizophrenia.

Authors:  Maren Carbon; Christoph U Correll
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

6.  Cognitive impairment in schizophrenia across age groups: a case-control study.

Authors:  Anna Mosiołek; Jacek Gierus; Tytus Koweszko; Agata Szulc
Journal:  BMC Psychiatry       Date:  2016-02-24       Impact factor: 3.630

7.  Neuropsychological Profile of Specific Executive Dysfunctions in Patients with Deficit and Non-deficit Schizophrenia.

Authors:  Ernest Tyburski; Justyna Pełka-Wysiecka; Monika Mak; Agnieszka Samochowiec; Przemysław Bieńkowski; Jerzy Samochowiec
Journal:  Front Psychol       Date:  2017-08-30

Review 8.  Rehabilitation Interventions to Promote Recovery from Schizophrenia: A Systematic Review.

Authors:  Laurent Morin; Nicolas Franck
Journal:  Front Psychiatry       Date:  2017-06-12       Impact factor: 4.157

Review 9.  Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia.

Authors:  Yash B Joshi; Gregory A Light
Journal:  Front Psychiatry       Date:  2018-11-19       Impact factor: 4.157

10.  Digital Technology Use Among Individuals with Schizophrenia: Results of an Online Survey.

Authors:  Katrina Gay; John Torous; Adam Joseph; Anand Pandya; Ken Duckworth
Journal:  JMIR Ment Health       Date:  2016-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.